Results For "CDMO-growth"

1 News Found

Laurus Labs FY26 revenue rises 23% to Rs 6,813 Crore; EBITDA surges 64%

Biopharma | May 01, 2026

Laurus Labs FY26 revenue rises 23% to Rs 6,813 Crore; EBITDA surges 64%

Strong CDMO growth, improved product mix and operational leverage drive profitability expansion

Latest Stories

Pawan Varshney elevated to Director of Finance – South Asia at Cepheid

Nitin Wadhwa joins Sebia as General Manager to lead India growth

PFCD panel flags insurance gaps limiting access to robotic joint replacement in India

White Papers

Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants

Implementing a digital transformation in chemical operations to maximize profitability

The complexity of compliance

The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation

The guiding role of fluidized and spouted bed technologies in particle building processes

Interviews

Patient-centric innovation driving fight against neglected diseases: Sanjay Sarin, Continental Lead Asia and South Asia Director, DNDi

Patient-centric innovation driving fight against neglected diseases: Sanjay Sarin, Continental Lead Asia and South Asia Director, DNDi

Sanjay Sarin, Continental Lead Asia and South Asia Director, DNDi

Our hybrid model combines global manufacturing with local clinical scale: Kavinder Beniwal, Chief Operational Officer, Motorica India

Our hybrid model combines global manufacturing with local clinical scale: Kavinder Beniwal, Chief Operational Officer, Motorica India

Kavinder Beniwal Chief Operational Officer, Motorica India

Betting on NK-cell innovation and combination immunotherapy to build global clinical-stage biotech: Dr Maloy Ghosh, CSO, Zumutor Biologics

Betting on NK-cell innovation and combination immunotherapy to build global clinical-stage biotech: Dr Maloy Ghosh, CSO, Zumutor Biologics

Dr Maloy Ghosh Chief Scientific Officer, Zumutor Biologics

Packaging